RDYDr. Reddy's Laboratories Limited
$13.19-7.2% 1Y
$13.19
$11.4052 weeks$15.40
Is the price fair?
What RDY's price assumes
Dr. Reddy's Laboratories Limited has no trailing P/E on file, so the price is measured against sales instead: 0.01× revenue.
0.01
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.03
Price / book · as of 2025-FY
- EV / sales
- 0.00
EV / sales
Details›
- Price / bookas of 2025-FY
- 0.03
- EV / EBITas of 2025-FY
- 0.02
- EV / salesas of 2025-FY
- 0.00
- Market capitalisation834.7 million shares, counted Mar 31, 2026
- $11.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Drug Manufacturers, Specialty & Generic
Ranks #2 of 39 by RyuScore